img

Global Colon Cancer Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Colon Cancer Market Research Report 2024

Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation.
According to MRAResearch’s new survey, global Colon Cancer market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Colon Cancer market research.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Colon Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bedford Laboratories
Sanofi Aventis
Bayer
GlaxoSmithKline
Teva Pharmaceutical Industries
Segment by Type
Surgery
Chemotherapy
Radiation

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Colon Cancer report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colon Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation
1.3 Market by Application
1.3.1 Global Colon Cancer Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colon Cancer Market Perspective (2018-2033)
2.2 Colon Cancer Growth Trends by Region
2.2.1 Global Colon Cancer Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Colon Cancer Historic Market Size by Region (2018-2023)
2.2.3 Colon Cancer Forecasted Market Size by Region (2024-2033)
2.3 Colon Cancer Market Dynamics
2.3.1 Colon Cancer Industry Trends
2.3.2 Colon Cancer Market Drivers
2.3.3 Colon Cancer Market Challenges
2.3.4 Colon Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colon Cancer Players by Revenue
3.1.1 Global Top Colon Cancer Players by Revenue (2018-2023)
3.1.2 Global Colon Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Colon Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colon Cancer Revenue
3.4 Global Colon Cancer Market Concentration Ratio
3.4.1 Global Colon Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colon Cancer Revenue in 2022
3.5 Colon Cancer Key Players Head office and Area Served
3.6 Key Players Colon Cancer Product Solution and Service
3.7 Date of Enter into Colon Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colon Cancer Breakdown Data by Type
4.1 Global Colon Cancer Historic Market Size by Type (2018-2023)
4.2 Global Colon Cancer Forecasted Market Size by Type (2024-2033)
5 Colon Cancer Breakdown Data by Application
5.1 Global Colon Cancer Historic Market Size by Application (2018-2023)
5.2 Global Colon Cancer Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Colon Cancer Market Size (2018-2033)
6.2 North America Colon Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Colon Cancer Market Size by Country (2018-2023)
6.4 North America Colon Cancer Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colon Cancer Market Size (2018-2033)
7.2 Europe Colon Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Colon Cancer Market Size by Country (2018-2023)
7.4 Europe Colon Cancer Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colon Cancer Market Size (2018-2033)
8.2 Asia-Pacific Colon Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Colon Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific Colon Cancer Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colon Cancer Market Size (2018-2033)
9.2 Latin America Colon Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Colon Cancer Market Size by Country (2018-2023)
9.4 Latin America Colon Cancer Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colon Cancer Market Size (2018-2033)
10.2 Middle East & Africa Colon Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Colon Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa Colon Cancer Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bedford Laboratories
11.1.1 Bedford Laboratories Company Detail
11.1.2 Bedford Laboratories Business Overview
11.1.3 Bedford Laboratories Colon Cancer Introduction
11.1.4 Bedford Laboratories Revenue in Colon Cancer Business (2018-2023)
11.1.5 Bedford Laboratories Recent Development
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Company Detail
11.2.2 Sanofi Aventis Business Overview
11.2.3 Sanofi Aventis Colon Cancer Introduction
11.2.4 Sanofi Aventis Revenue in Colon Cancer Business (2018-2023)
11.2.5 Sanofi Aventis Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Colon Cancer Introduction
11.3.4 Bayer Revenue in Colon Cancer Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Colon Cancer Introduction
11.4.4 GlaxoSmithKline Revenue in Colon Cancer Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Colon Cancer Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Colon Cancer Business (2018-2023)
11.5.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Colon Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation
Table 5. Global Colon Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Colon Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Colon Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Colon Cancer Market Share by Region (2018-2023)
Table 9. Global Colon Cancer Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Colon Cancer Market Share by Region (2024-2033)
Table 11. Colon Cancer Market Trends
Table 12. Colon Cancer Market Drivers
Table 13. Colon Cancer Market Challenges
Table 14. Colon Cancer Market Restraints
Table 15. Global Colon Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Colon Cancer Market Share by Players (2018-2023)
Table 17. Global Top Colon Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colon Cancer as of 2022)
Table 18. Ranking of Global Top Colon Cancer Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Colon Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Colon Cancer Product Solution and Service
Table 22. Date of Enter into Colon Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Colon Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Colon Cancer Revenue Market Share by Type (2018-2023)
Table 26. Global Colon Cancer Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Colon Cancer Revenue Market Share by Type (2024-2033)
Table 28. Global Colon Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Colon Cancer Revenue Market Share by Application (2018-2023)
Table 30. Global Colon Cancer Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Colon Cancer Revenue Market Share by Application (2024-2033)
Table 32. North America Colon Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Colon Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Colon Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Colon Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Colon Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Colon Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Colon Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Colon Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Colon Cancer Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Colon Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Colon Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Colon Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Colon Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Colon Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Colon Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 47. Bedford Laboratories Company Detail
Table 48. Bedford Laboratories Business Overview
Table 49. Bedford Laboratories Colon Cancer Product
Table 50. Bedford Laboratories Revenue in Colon Cancer Business (2018-2023) & (US$ Million)
Table 51. Bedford Laboratories Recent Development
Table 52. Sanofi Aventis Company Detail
Table 53. Sanofi Aventis Business Overview
Table 54. Sanofi Aventis Colon Cancer Product
Table 55. Sanofi Aventis Revenue in Colon Cancer Business (2018-2023) & (US$ Million)
Table 56. Sanofi Aventis Recent Development
Table 57. Bayer Company Detail
Table 58. Bayer Business Overview
Table 59. Bayer Colon Cancer Product
Table 60. Bayer Revenue in Colon Cancer Business (2018-2023) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. GlaxoSmithKline Company Detail
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Colon Cancer Product
Table 65. GlaxoSmithKline Revenue in Colon Cancer Business (2018-2023) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Teva Pharmaceutical Industries Company Detail
Table 68. Teva Pharmaceutical Industries Business Overview
Table 69. Teva Pharmaceutical Industries Colon Cancer Product
Table 70. Teva Pharmaceutical Industries Revenue in Colon Cancer Business (2018-2023) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colon Cancer Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Colon Cancer Market Share by Type: 2022 VS 2033
Figure 3. Surgery Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Features
Figure 6. Global Colon Cancer Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Colon Cancer Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Colon Cancer Report Years Considered
Figure 12. Global Colon Cancer Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Colon Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Colon Cancer Market Share by Region: 2022 VS 2033
Figure 15. Global Colon Cancer Market Share by Players in 2022
Figure 16. Global Top Colon Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colon Cancer as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Colon Cancer Revenue in 2022
Figure 18. North America Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Colon Cancer Market Share by Country (2018-2033)
Figure 20. United States Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Colon Cancer Market Share by Country (2018-2033)
Figure 24. Germany Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Colon Cancer Market Share by Region (2018-2033)
Figure 32. China Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Colon Cancer Market Share by Country (2018-2033)
Figure 40. Mexico Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Colon Cancer Market Share by Country (2018-2033)
Figure 44. Turkey Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Colon Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Bedford Laboratories Revenue Growth Rate in Colon Cancer Business (2018-2023)
Figure 47. Sanofi Aventis Revenue Growth Rate in Colon Cancer Business (2018-2023)
Figure 48. Bayer Revenue Growth Rate in Colon Cancer Business (2018-2023)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Colon Cancer Business (2018-2023)
Figure 50. Teva Pharmaceutical Industries Revenue Growth Rate in Colon Cancer Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed